Priority Date: 11.11.11 (US 201161558953P)

CYCLIN A1-TARGETED T-CELL IMMUNOTHERAPY FOR CANCER

  • Application ID: EP12848741
  • Status: EXAMINATION IN PROGRESS

Attorney

Company dna icosa
no operation time available
733.99
1 office
active in Legal Services

Specialization

This EP application has the IPC combination A61, C07, and C12. Icosa is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 125 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 11.11.2011 - Priority Date (US 201161558953P)
  • 16.05.2013 - Publication A1 (WO2013071154)
  • 17.09.2014 - Publication A1 (EP2776451)